Free Trial
→ Why More Investors Are Using Family Trusts to Protect Their Wealth (From SmartAsset) (Ad)tc pixel Free BMRN Stock Alerts

BioMarin Pharmaceutical (BMRN) SEC Filings & 10K Form

BioMarin Pharmaceutical logo
$53.41 -0.53 (-0.98%)
Closing price 04:00 PM Eastern
Extended Trading
$53.40 -0.01 (-0.03%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent BioMarin Pharmaceutical SEC Filings

Export to Excel
DateFilerForm TypeView
08/14/2025
4:32 PM		BioMarin Pharmaceutical (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SCHEDULE 13G/A
08/14/2025
11:43 AM		BioMarin Pharmaceutical (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SCHEDULE 13G/A
08/05/2025
5:51 PM		BioMarin Pharmaceutical (Issuer)
CLARK IAN T (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/05/2025
5:55 PM		BioMarin Pharmaceutical (Issuer)
CLARK IAN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
12:03 PM		BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/01/2025
8:18 AM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-T/A
06/17/2025
6:28 AM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-T/A
06/04/2025
3:32 PM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-T/A
06/02/2025
5:25 AM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-T
05/20/2025
4:58 PM		BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
8:58 AM		BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2025
4:22 PM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-C
05/16/2025
8:44 PM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-C
05/16/2025
4:16 PM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-C
05/16/2025
6:54 AM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2025
6:59 AM		BioMarin Pharmaceutical (Subject)
Form SC TO-C
05/13/2025
10:32 AM		BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
Form SCHEDULE 13G/A
05/02/2025
11:33 AM		BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2025
9:05 AM		BioMarin Pharmaceutical (Subject)
Hubbard Cristin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/29/2025
8:14 AM		BioMarin Pharmaceutical (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
04/08/2025
3:09 PM		BioMarin Pharmaceutical (Filer)
Form DEF 14A
04/08/2025
3:12 PM		BioMarin Pharmaceutical (Filer)
Form DEFA14A
03/20/2025
6:38 PM		BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
8:36 AM		BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
6:51 PM		BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:53 PM		BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:23 PM		BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:25 PM		BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:17 PM		BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:19 PM		BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:22 PM		BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:11 PM		BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:15 PM		BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:17 PM		BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:19 PM		BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:18 PM		BioMarin Pharmaceutical (Issuer)
Walbert Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:21 PM		BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
12:54 PM		BioMarin Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
9:26 AM		BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
3:07 PM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
1:14 PM		BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
Form SCHEDULE 13G/A
12/03/2024
5:15 PM		BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
1:44 PM		BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
1:27 PM		BioMarin Pharmaceutical (Subject)
Guyer Charles Greg (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
2:01 PM		BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/01/2024
3:50 PM		BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2024
3:51 PM		BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:29 PM		BioMarin Pharmaceutical (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G
09/24/2024
7:31 AM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:BMRN) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel
Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...
SmartAsset | Sponsoredtc pixel
Strange crypto pattern discovered by 40-person research team
Something unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...
Crypto Swap Profits | Sponsoredtc pixel
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel